Crescent Biopharma Q3 EPS $(1.27) Beats $(1.98) Estimate
Benzinga Newsdesk 12 months ago
EarningsEarnings BeatsNews
Crescent Biopharma (NASDAQ:CBIO) reported quarterly losses of $(1.27) per share which beat the analyst consensus estimate of $(1.98) by 35.92 percent.
Crescent Biopharma (NASDAQ:CBIO) reported quarterly losses of $(1.27) per share which beat the analyst consensus estimate of $(1.98) by 35.92 percent.